Status:
COMPLETED
Treatment for Insomnia During Pregnancy
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Conditions:
Sleep Initiation and Maintenance Disorders
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The aim of the study is to improve sleep during pregnancy and the postpartum period in women who are experiencing insomnia, using a brief non-pharmacological treatment.
Eligibility Criteria
Inclusion
- Meets Diagnostic and Statistical Manual (IV-TR edition) criteria for insomnia (duration criterion - 1 month)
- Pregnant with gestational age between 18-32 weeks.
- Adequately fluent in English or Spanish.
Exclusion
- Some co-morbid sleep disorders (e.g., moderate to severe obstructive sleep apnea)
- Co-morbid psychiatric disorder
- Use of medications, herbs or other drugs with known effects on sleep
- Unstable medical conditions
- Currently engaged in psychotherapy or other treatments for insomnia
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2018
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT01846585
Start Date
April 1 2013
End Date
March 1 2018
Last Update
July 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94305